These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32633172)

  • 41. Effects of visual information on intelligibility of open and closed class words in predictable sentences produced by speakers with dysarthria.
    Hustad KC; Dardis CM; McCourt KA
    Clin Linguist Phon; 2007 May; 21(5):353-67. PubMed ID: 17468995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contribution of two sources of listener knowledge to intelligibility of speakers with cerebral palsy.
    Hustad KC
    J Speech Lang Hear Res; 2007 Oct; 50(5):1228-40. PubMed ID: 17905908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Speech and communication in Parkinson's disease: a cross-sectional exploratory study in the UK.
    Barnish MS; Horton SMC; Butterfint ZR; Clark AB; Atkinson RA; Deane KHO
    BMJ Open; 2017 May; 7(5):e014642. PubMed ID: 28554918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protocol for the Evaluation of Speech Intelligibility in Dysarthrias: Evidence of Reliability and Validity.
    dos Santos Barreto S; Zazo Ortiz K
    Folia Phoniatr Logop; 2015; 67(4):212-8. PubMed ID: 26771521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Educational Information Improves Listener Attitudes Toward People With Dysarthria Secondary to Parkinson's Disease.
    Fletcher AR; Potts MW; Borrie SA
    Am J Speech Lang Pathol; 2023 May; 32(3):1099-1109. PubMed ID: 36881856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dysarthria and Speech Intelligibility Following Parkinson's Disease Globus Pallidus Internus Deep Brain Stimulation.
    Chiu SY; Tsuboi T; Hegland KW; Herndon NE; Shukla AW; Patterson A; Almeida L; Foote KD; Okun MS; Ramirez-Zamora A
    J Parkinsons Dis; 2020; 10(4):1493-1502. PubMed ID: 32955467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intelligibility in dysarthria: effects of listener familiarity and speaking condition.
    D'Innocenzo J; Tjaden K; Greenman G
    Clin Linguist Phon; 2006 Nov; 20(9):659-75. PubMed ID: 17342875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Variation in Speech Intelligibility Ratings as a Function of Speech Rate Modification in Parkinson's Disease.
    Knowles T; Adams SG; Jog M
    J Speech Lang Hear Res; 2021 Jun; 64(6):1773-1793. PubMed ID: 33950711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessing speech intelligibility of pathological speech in sentences and word lists: The contribution of phoneme-level measures.
    Xue W; van Hout R; Cucchiarini C; Strik H
    J Commun Disord; 2023; 102():106301. PubMed ID: 36709701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation and cross-linguistic adaptation of the Frenchay Dysarthria Assessment (FDA-2) speech intelligibility tests: Hebrew version.
    Icht M; Bergerzon-Bitton O; Ben-David BM
    Int J Lang Commun Disord; 2022 Sep; 57(5):1023-1049. PubMed ID: 35714104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acoustic and intelligibility characteristics of sentence production in neurogenic speech disorders.
    Weismer G; Jeng JY; Laures JS; Kent RD; Kent JF
    Folia Phoniatr Logop; 2001; 53(1):1-18. PubMed ID: 11125256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hybridizing conversational and clear speech to investigate the source of increased intelligibility in speakers with Parkinson's disease.
    Tjaden K; Kain A; Lam J
    J Speech Lang Hear Res; 2014 Aug; 57(4):1191-205. PubMed ID: 24686409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Phonetic Complexity-Based Approach for Intelligibility and Articulatory Precision Testing: A Preliminary Study on Talkers With Amyotrophic Lateral Sclerosis.
    Kuruvilla-Dugdale M; Custer C; Heidrick L; Barohn R; Govindarajan R
    J Speech Lang Hear Res; 2018 Sep; 61(9):2205-2214. PubMed ID: 30208408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Minimally Detectable Change of Speech Intelligibility in Speakers With Multiple Sclerosis and Parkinson's Disease.
    Stipancic KL; Tjaden K
    J Speech Lang Hear Res; 2022 May; 65(5):1858-1866. PubMed ID: 35442761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of level of presentation to listeners on scaled speech intelligibility of speakers with dysarthria.
    Kim Y; Kuo C
    Folia Phoniatr Logop; 2012; 64(1):26-33. PubMed ID: 21952405
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dysarthric sentence intelligibility: contribution of iconic gestures and message predictiveness.
    Garcia JM; Dagenais PA
    J Speech Lang Hear Res; 1998 Dec; 41(6):1282-93. PubMed ID: 9859884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between acoustic measures and judgments of intelligibility in Parkinson's disease: a within-speaker approach.
    Feenaughty L; Tjaden K; Sussman J
    Clin Linguist Phon; 2014 Nov; 28(11):857-78. PubMed ID: 24874184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of linguistic cues and stimulus cohesion on intelligibility of severely dysarthric speech.
    Hustad KC; Beukelman DR
    J Speech Lang Hear Res; 2001 Jun; 44(3):497-510. PubMed ID: 11407556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease.
    De Letter M; Santens P; De Bodt M; Van Maele G; Van Borsel J; Boon P
    Clin Neurol Neurosurg; 2007 Jul; 109(6):495-500. PubMed ID: 17509751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.